Compare $NPCE vs $SI | Chartloom

Compare

$NPCE vs $SI

Neuropace Inc · Shoulder Innovations Inc

NPCE

Neuropace Inc

Shoulder Innovations Inc

Compare $NPCE vs $SI

Comparing Neuropace Inc and Shoulder Innovations Inc

NPCENeuropace Inc

SIShoulder Innovations Inc

NPCENeuropace Inc

Market cap

$432M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

3.83x

Rev growth (TTM)

11.6%

YTD performance

-16.5%

52W performance

13.8%

FCF yield

-2.7%

SIShoulder Innovations Inc

Market cap

$376M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

4.72x

Rev growth (TTM)

0.2%

YTD performance

26.2%

52W performance

39.4%

FCF yield

-12.5%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

NPCE

Detailed metrics comparison

NPCE

Neuropace Inc

Shoulder Innovations Inc

Market Cap

NPCE$432M

SI$376M

Enterprise Value

NPCE$478M

SI$366M

Price

NPCE$12.67

SI$18.13

P/E Ratio

NPCEN/A

SIN/A

P/S Ratio

NPCE4.37x

SI6.26x

EV/Sales

NPCE4.84x

SI6.10x

EV/EBITDA

NPCE0.00x

SI0.00x

P/B Ratio

NPCE36.68x

SI3.18x

P/FCF Ratio

NPCEN/A

SIN/A

EV/FCF

NPCE-41.21x

SI-7.78x

PEG Ratio

NPCEN/A

SIN/A

Forward P/E (NTM)

NPCEN/A

SIN/A

Forward P/S (NTM)

NPCE3.83x

SI4.72x

Revenue (TTM)

NPCE$99M

SI$60M

Revenue Growth (YoY)

NPCE11.6%

SI0.2%

Forward Rev Growth

NPCE22.0%

SI29.2%

Gross Margin (TTM)

NPCE79.6%

SI77.3%

Operating Margin (TTM)

NPCE0.0%

SI0.0%

EBITDA Margin (TTM)

NPCE-15.0%

SI-51.7%

Net Margin (TTM)

NPCE-19.3%

SI-11.5%

FCF Margin (TTM)

NPCE-11.7%

SI-78.4%

Net Income (TTM)

NPCE$-19M

SI$-7M

FCF (TTM)

NPCE$-12M

SI$-47M

EPS (TTM)

NPCE-$0.56

SI-$0.33

ROE (TTM)

NPCE-11968.0%

SI-506.0%

ROA (TTM)

NPCE-1871.0%

SI-419.0%

ROIC (TTM)

NPCE-2552.0%

SI-456.0%

Cash

NPCE$13M

SI$24M

Debt

NPCE$59M

SI$15M

Net Cash/Debt

NPCE$-46M

SI$10M

Current Ratio (TTM)

NPCE4.94x

SI10.71x

Quick Ratio (TTM)

NPCE3.82x

SI8.74x

Debt/Equity (TTM)

NPCE4.97x

SI0.12x

Debt/Assets (TTM)

NPCE0.0%

SI0.0%

Interest Coverage (TTM)

NPCEN/A

SIN/A

Net Debt/EBITDA (TTM)

NPCE0.00x

SI0.00x

Beta

NPCE1.95

SI15.37

52W Performance

NPCE13.8%

SI39.4%

YTD Performance

NPCE-16.5%

SI26.2%

% from 52W High

NPCE-35.4%

SI-26.3%

% from 52W Low

NPCE37.4%

SI66.0%

Asset Turnover (TTM)

NPCE0.97x

SI0.30x

FCF Yield (TTM)

NPCE-2.7%

SI-12.5%

Earnings Yield (TTM)

NPCE-4.4%

SI-1.8%

Dividend Yield (TTM)

NPCEN/A

SIN/A

Rule of 40

NPCE-0.2

SI-78.2

EV/GP/RG

NPCE0.40

SI0.19

Ticker research

View NPCE research View SI research

Metric	NPCE Neuropace Inc	SI Shoulder Innovations Inc
Market & Valuation
Market Cap	$432M	$376M
Enterprise Value	$478M	$366M
Price	$12.67	$18.13
P/E Ratio	N/A	N/A
P/S Ratio	4.37x	6.26x
EV/Sales	4.84x	6.10x
EV/EBITDA	0.00x	0.00x
P/B Ratio	36.68x	3.18x
P/FCF Ratio	N/A	N/A
EV/FCF	-41.21x	-7.78x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	3.83x	4.72x
Revenue & Growth
Revenue (TTM)	$99M	$60M
Revenue Growth (YoY)	11.6%	0.2%
Forward Rev Growth	22.0%	29.2%
Profitability
Gross Margin (TTM)	79.6%	77.3%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-15.0%	-51.7%
Net Margin (TTM)	-19.3%	-11.5%
FCF Margin (TTM)	-11.7%	-78.4%
Net Income (TTM)	$-19M	$-7M
FCF (TTM)	$-12M	$-47M
EPS (TTM)	-$0.56	-$0.33
ROE (TTM)	-11968.0%	-506.0%
ROA (TTM)	-1871.0%	-419.0%
ROIC (TTM)	-2552.0%	-456.0%
Financial Health
Cash	$13M	$24M
Debt	$59M	$15M
Net Cash/Debt	$-46M	$10M
Current Ratio (TTM)	4.94x	10.71x
Quick Ratio (TTM)	3.82x	8.74x
Debt/Equity (TTM)	4.97x	0.12x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.95	15.37
52W Performance	13.8%	39.4%
YTD Performance	-16.5%	26.2%
% from 52W High	-35.4%	-26.3%
% from 52W Low	37.4%	66.0%
Efficiency & Yields
Asset Turnover (TTM)	0.97x	0.30x
FCF Yield (TTM)	-2.7%	-12.5%
Earnings Yield (TTM)	-4.4%	-1.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-0.2	-78.2
EV/GP/RG	0.40	0.19
Ticker research	View NPCE research	View SI research

Valuation

P/S Ratio

NPCE

4.37x

6.26x

EV/FCF

NPCE

-41.21x

-7.78x

Growth & revenue

Revenue Growth TTM

NPCE

11.6%

0.2%

Forward Revenue Growth

29.2%

NPCE

22.0%

Profitability & performance

Gross Margin

NPCE

79.6%

77.3%

ROE

-506.0%

NPCE

-11968.0%

FCF Yield %

NPCE

-2.7%

-12.5%

52-Week Performance

39.4%

NPCE

13.8%

Detailed metrics comparison

NPCE

Neuropace Inc

Shoulder Innovations Inc

Market Cap

NPCE$432M

SI$376M

Enterprise Value

NPCE$478M

SI$366M

Price

NPCE$12.67

SI$18.13

P/E Ratio

NPCEN/A

SIN/A

P/S Ratio

NPCE4.37x

SI6.26x

EV/Sales

NPCE4.84x

SI6.10x

EV/EBITDA

NPCE0.00x

SI0.00x

P/B Ratio

NPCE36.68x

SI3.18x

P/FCF Ratio

NPCEN/A

SIN/A

EV/FCF

NPCE-41.21x

SI-7.78x

PEG Ratio

NPCEN/A

SIN/A

Forward P/E (NTM)

NPCEN/A

SIN/A

Forward P/S (NTM)

NPCE3.83x

SI4.72x

Revenue (TTM)

NPCE$99M

SI$60M

Revenue Growth (YoY)

NPCE11.6%

SI0.2%

Forward Rev Growth

NPCE22.0%

SI29.2%

Gross Margin (TTM)

NPCE79.6%

SI77.3%

Operating Margin (TTM)

NPCE0.0%

SI0.0%

EBITDA Margin (TTM)

NPCE-15.0%

SI-51.7%

Net Margin (TTM)

NPCE-19.3%

SI-11.5%

FCF Margin (TTM)

NPCE-11.7%

SI-78.4%

Net Income (TTM)

NPCE$-19M

SI$-7M

FCF (TTM)

NPCE$-12M

SI$-47M

EPS (TTM)

NPCE-$0.56

SI-$0.33

ROE (TTM)

NPCE-11968.0%

SI-506.0%

ROA (TTM)

NPCE-1871.0%

SI-419.0%

ROIC (TTM)

NPCE-2552.0%

SI-456.0%

Cash

NPCE$13M

SI$24M

Debt

NPCE$59M

SI$15M

Net Cash/Debt

NPCE$-46M

SI$10M

Current Ratio (TTM)

NPCE4.94x

SI10.71x

Quick Ratio (TTM)

NPCE3.82x

SI8.74x

Debt/Equity (TTM)

NPCE4.97x

SI0.12x

Debt/Assets (TTM)

NPCE0.0%

SI0.0%

Interest Coverage (TTM)

NPCEN/A

SIN/A

Net Debt/EBITDA (TTM)

NPCE0.00x

SI0.00x

Beta

NPCE1.95

SI15.37

52W Performance

NPCE13.8%

SI39.4%

YTD Performance

NPCE-16.5%

SI26.2%

% from 52W High

NPCE-35.4%

SI-26.3%

% from 52W Low

NPCE37.4%

SI66.0%

Asset Turnover (TTM)

NPCE0.97x

SI0.30x

FCF Yield (TTM)

NPCE-2.7%

SI-12.5%

Earnings Yield (TTM)

NPCE-4.4%

SI-1.8%

Dividend Yield (TTM)

NPCEN/A

SIN/A

Rule of 40

NPCE-0.2

SI-78.2

EV/GP/RG

NPCE0.40

SI0.19

Ticker research

View NPCE research View SI research

Metric	NPCE Neuropace Inc	SI Shoulder Innovations Inc
Market & Valuation
Market Cap	$432M	$376M
Enterprise Value	$478M	$366M
Price	$12.67	$18.13
P/E Ratio	N/A	N/A
P/S Ratio	4.37x	6.26x
EV/Sales	4.84x	6.10x
EV/EBITDA	0.00x	0.00x
P/B Ratio	36.68x	3.18x
P/FCF Ratio	N/A	N/A
EV/FCF	-41.21x	-7.78x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	3.83x	4.72x
Revenue & Growth
Revenue (TTM)	$99M	$60M
Revenue Growth (YoY)	11.6%	0.2%
Forward Rev Growth	22.0%	29.2%
Profitability
Gross Margin (TTM)	79.6%	77.3%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-15.0%	-51.7%
Net Margin (TTM)	-19.3%	-11.5%
FCF Margin (TTM)	-11.7%	-78.4%
Net Income (TTM)	$-19M	$-7M
FCF (TTM)	$-12M	$-47M
EPS (TTM)	-$0.56	-$0.33
ROE (TTM)	-11968.0%	-506.0%
ROA (TTM)	-1871.0%	-419.0%
ROIC (TTM)	-2552.0%	-456.0%
Financial Health
Cash	$13M	$24M
Debt	$59M	$15M
Net Cash/Debt	$-46M	$10M
Current Ratio (TTM)	4.94x	10.71x
Quick Ratio (TTM)	3.82x	8.74x
Debt/Equity (TTM)	4.97x	0.12x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.95	15.37
52W Performance	13.8%	39.4%
YTD Performance	-16.5%	26.2%
% from 52W High	-35.4%	-26.3%
% from 52W Low	37.4%	66.0%
Efficiency & Yields
Asset Turnover (TTM)	0.97x	0.30x
FCF Yield (TTM)	-2.7%	-12.5%
Earnings Yield (TTM)	-4.4%	-1.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-0.2	-78.2
EV/GP/RG	0.40	0.19
Ticker research	View NPCE research	View SI research